EAPCI Column

DOI:

EAPCI Fellowship Grants: Why you should apply. An interview with Dr Kasparas Briedis, the 2018 EAPCI Fellowship Grant winner

Why did you apply for an EAPCI Fellowship Grant?

In Lithuania, despite robust clinical facilities, a significant gap existed in heart valve interventions; my ambition was ignited to bridge this gap. The EAPCI Fellowship Grant emerged as a pathway enabling me to acquire international experience and proficiency, imperative for enhancing catheter-based valve implantations in Lithuania. This opportunity addressed the increasing need for highly qualified specialists capable of performing intricate procedures while minimising the risk for complications.

How did you choose your host centre for your EAPCI Fellowship?

The Liverpool Heart and Chest Hospital in the UK, recognised for its extensive adult congenital heart disease program and high rate of heart valve interventions, resonated with my commitment to excellence and specialisation. It was a profound honour to gain insights and learn procedures from world-renowned, leading interventional cardiologists in this high-calibre institution.

What did you focus on during your EAPCI Fellowship?

A concrete focus during my fellowship was to achieve proficiency as an independent primary operator in transcatheter aortic valve implantation (TAVI). I dedicated myself to understanding every potential procedural complication and meticulously mastering steps to ensure procedural success. Beyond technical skills, I was keen to grasp the comprehensive logistical steps, including patient referrals, outpatient clinics, and multidisciplinary team (MDT) meetings, establishing a solid foundation in this service.

Did the EAPCI Fellowship fulfil your objectives?

The EAPCI Fellowship proved transformative: working within the English National Health Service (NHS) enriched my understanding of principles like clinical effectiveness, risk management, and continuous learning and development. I actively engaged in multiple facets of structural heart interventions, contributing to, and learning from MDT meetings, patient screenings, outpatient clinics, without overlooking the on-call night shifts. This comprehensive involvement reinforced my confidence and expertise, equipping me for future challenges and opportunities.

What difficulties did you encounter during your fellowship?

As with any move to another country, there are differences rather than difficulties, and I encountered valuable challenges that moulded and refined my professional journey. Every new obstacle became a learning opportunity, bolstering my resilience, confidence, and proficiency, and contributing to an enhanced sense of achievement and progress.

How has your EAPCI Fellowship benefitted your career development?

Post-fellowship, my career witnessed a significant upsurge. The international experience endowed me with a distinctive reputation and a solidified position within Lithuania’s structural heart intervention teams. This foundation facilitated my engagement in clinical trials with new medical devices and first-in-human experiences in structural heart interventions. My endeavour didn’t stop there. I was privileged to win a scholarship from the European Society of Cardiology to pursue the Executive Master’s program in Health Economics, Outcomes, and Management in Cardiovascular Sciences at the prestigious London School of Economics and Political Science, further refining my skills in health economics and management. Now, I actively contribute to the elevation of the healthcare services in Lithuania, applying my accumulated knowledge and fostering international collaborations. My responsibilities as a lecturer at the Faculty of Medicine of the Lithuanian University of Health Sciences, coupled with my full-time clinical role, showcase the comprehensive enhancement of my career and contributions to healthcare. Having successfully earned my PhD, I continue to leverage this academic accomplishment to further amplify my impact in the medical field, underscoring my commitment to advancing healthcare standards both nationally and internationally. Finally, after achieving proficiency in TAVI procedures, I have proudly become a TAVI proctor for many renowned medical companies. This role allows me to share my experiences and skills globally, further enriching the professional community and contributing to the advancement of cardiovascular interventions worldwide.

What advice would you have for future applicants?

Potential EAPCI Fellowship Grant applicants, seize this life-altering opportunity with both hands. This platform is not just a stepping stone for your professional growth but also a chance to make a monumental impact on global cardiovascular healthcare. This journey, while demanding and filled with challenges, will be the catalyst for your extensive learning, growth, and the realisation of your most ambitious dreams in the world of cardiovascular care. Embark on this extraordinary journey, arm yourself with newfound knowledge, and let your contribution resonate worldwide.

Apply now for the 2024 EAPCI Fellowship Grants

https://www.escardio.org/Education/Career-Development/Grants-and-fellowships/EAPCI-interventional-cardiology-training-and-research-grants

Volume 19 Number 11
Dec 18, 2023
Volume 19 Number 11
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00029 Aug 4, 2025
Coronary sinus Reducer for the treatment of refractory angina: how much more evidence do we need?
Al-Lamee R and Foley M
free

Expert Review

10.4244/EIJ-D-24-00812 Aug 4, 2025
Management of device embolisation during left atrial appendage closure
Kefer J et al
free

Research Correspondence

10.4244/EIJ-D-24-01123 Aug 4, 2025
Coronary sinus narrowing for the treatment of refractory angina: one-year results of the REDUCER-I study
Verheye S et al

Editorial

10.4244/EIJ-E-25-00030 Aug 4, 2025
Expanding the boundaries of M-TEER: is it time to treat moderate secondary mitral regurgitation?
Adamo M and Riccardi M
free

Editorial

10.4244/EIJ-E-25-00035 Aug 4, 2025
The promise and pitfalls of registries for transcatheter tricuspid valve intervention
Hahn R
free

Original Research

10.4244/EIJ-D-24-01174 Aug 4, 2025
Transcatheter valve repair of tricuspid regurgitation: 1-year outcomes from the TriCLASP study
Baldus S et al
Trending articles
172.65

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
95.95

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
63

Image – Interventional flashlight

10.4244/EIJ-D-22-00074 Jun 3, 2022
Transcatheter aortic valve repair for aortic regurgitation with the Cusper device
Feld Y et al
free
58.55

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
49.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
31.35

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
30.4

Clinical Research

10.4244/EIJ-D-21-00363 Jan 28, 2022
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation
Jørgensen T et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved